(NASDAQ:FWRG), BRADENTON, Fla., Nov. 25, 2025 (GLOBE NEWSWIRE) — First Watch Restaurant Group, Inc., (Nasdaq: FWRG) (“First Watch” or the “Company”), the leading Daytime Dining concept serving breakfast, brunch and lunch, today announced it will participate in two investor conferences in December: The Company will meet with institutional investors and host a fireside chat at […]

(NasdaqGM:NAMS),(NasdaqGM:NAMSW), NAARDEN, The Netherlands and MIAMI, Nov. 25, 2025 (GLOBE NEWSWIRE) — NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical company developing oral, non-statin medicines for patients at risk of cardiovascular disease (“CVD”) with elevated low-density lipoprotein cholesterol (“LDL-C”), for whom existing therapies are not sufficiently effective or

(NASDAQ:NVCT), Fort Lee, NJ, Nov. 25, 2025 (GLOBE NEWSWIRE) — Nuvectis Pharma, Inc. (NASDAQ: NVCT, the “Company”), a clinical stage biopharmaceutical company focused on the development of innovative precision medicines for the treatment of serious conditions of unmet medical need in oncology, today announced that the Company will host a virtual Key Opinion Leader Meeting

(TSX:TSND),(OTC US:TSNDF),(Other OTC:TSNDF), TORONTO, Nov. 25, 2025 (GLOBE NEWSWIRE) — TerrAscend Corp. (“TerrAscend” or the “Company”) (TSX: TSND) (OTCQX: TSNDF), a leading North American cannabis company, today announced an exclusive licensing agreement with Tyson 2.0, the cannabis brand founded by Mike Tyson, to launch its products across Maryland and Pennsylvania. “Cannabis changed my life, and

Tustin, Ca, Nov. 25, 2025 (GLOBE NEWSWIRE) — Canon Medical Systems USA announced that its latest innovation in interventional cardiology imaging–the Alphenix / Evolve Edition with αEvolve Imaging–had received FDA 510(k) clearance, paving the way for enhanced procedural precision and clinical confidence. Utilizing deep learning technology in real-time, the Alphenix / Evolve Edition is designed

(NasdaqGM:FATE), SAN DIEGO, Nov. 25, 2025 (GLOBE NEWSWIRE) — Fate Therapeutics, Inc. (the “Company” or “Fate Therapeutics”) (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent stem cell (iPSC)-derived cellular immunotherapies to patients with cancer and autoimmune diseases, today announced that the Company will present at the Piper Sandler

(NASDAQ:DKNG), BOSTON, Nov. 25, 2025 (GLOBE NEWSWIRE) — DraftKings Inc. (NASDAQ: DKNG) (“DraftKings”) today announced the launch of a Spanish-language experience available within the DraftKings Sportsbook & Casino app. This new functionality marks a significant step in DraftKings' ongoing effort to deliver a product uniquely tailored to each of its customers' individual preferences. “Today, Spanish-speaking

(NASDAQ:CMPX), BOSTON, Nov. 25, 2025 (GLOBE NEWSWIRE) — Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics, today announced that the Company will participate in the following investor events during the month of December. Details are as follows: Piper Sandler 37th Annual Healthcare Conference Location: New York, NYDate: Tuesday, December

(NASDAQ:ZSPC), SAN JOSE, Calif., Nov. 25, 2025 (GLOBE NEWSWIRE) — zSpace, Inc. (NASDAQ: ZSPC), a global leader in immersive augmented reality (AR) learning solutions for education, today announced that Boca Raton Community Middle School, home to 1,000 students in Palm Beach County, has reimagined career exploration and student engagement through the implementation of the zSpace

New York, NY, Nov. 25, 2025 (GLOBE NEWSWIRE) — GraniteShares, a one of the leading issuer of exchange-traded funds (ETFs), today announced the launch of two new additions to its growing YieldBOOST(TM) family offering investors new ways to access income opportunities from the fast-evolving quantum computing space. Ticker Fund Underlying Company RGYY GraniteShares YieldBOOST(TM) RGTI